Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 8/20 | 0.50 |
| ▸ | PKM | P14618 | 7/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 7/20 | 0.48 |
| ▸ | NPC1 | O15118 | 9/20 | 0.45 |
| ▸ | RAB9A | P51151 | 9/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26017593 | 0.86 | S1PR1 (0.49) | TP53PKMSMN1; SMN2MAPTTSHR | |
| SCHEMBL21771256 | 0.84 | S1PR1 (0.55) | TP53PKMSMN1; SMN2MAPTTSHR | |
| SCHEMBL13453336 | 0.74 | NPC1 (0.67) | TP53PKMSMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL4192798 | 0.73 | GRM5 (0.66) | TP53PKMSMN1; SMN2MAPTTSHR | |
| SCHEMBL21771094 | 0.73 | S1PR1 (0.57) | TP53PKMSMN1; SMN2MAPTTSHR | |
| SCHEMBL14329053 | 0.71 | S1PR1 (0.74) | SMN1; SMN2MAPTS1PR1S1PR3NPC1 | |
| SCHEMBL10596816 | 0.71 | CYP1A2 (0.55) | TP53PKMSMN1; SMN2MAPTTSHR | |
| SCHEMBL23523869 | 0.70 | HPGD (0.41) | TP53PKMSMN1; SMN2MAPTTSHR | |
| SCHEMBL21273251 | 0.70 | S1PR1 (0.53) | TP53PKMSMN1; SMN2MAPTTSHR | |
| SCHEMBL21282216 | 0.69 | NPC1 (0.54) | TP53PKMSMN1; SMN2MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11707452-B2 | Modulators of alpha-synuclein proteolysis and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11707452-B2 | Modulators of alpha-synuclein proteolysis and associated methods of use | UCHL1, ADRM1, CRBN | TP53 173/4885PKM 3372/4885SMN1; SMN2 269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.